Sign in
4

Changes in Ownership

Alzamend Neuro, Inc. Filed Acc 0001214659-25-014752

Director sold 139,412 shares at an average $2.47 ($344,222)

  • Director acquired 200,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

AULT MILTON C III · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-03 Conversion : show line 1 in the form +100,000 $2.32 $232,000 108,260 I
2025-10-06 Sale : show line 2 in the form −82,033 $2.45 $201,268 26,227 I
2025-10-07 Conversion : show line 3 in the form +100,000 $2.32 $232,000 126,227 I
2025-10-07 Sale : show line 4 in the form −57,379 $2.49 $142,954 68,848 I
Open-market sales · 139,412 sh · avg $2.47 · $344,222

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-03 Conversion : show line 5 in the form Series B Convertible Preferred Stock −232 $1,000.00 $232,000 375.24 I
2025-10-07 Conversion : show line 6 in the form Series B Convertible Preferred Stock −232 $1,000.00 $232,000 143.24 I
Loading xslF345X05/marketforms-71017.xml…